Sr. Alballa et al., THE EFFECTS OF CHOLESTYRAMINE AND COLESTIPOL ON THE ABSORPTION OF DICLOFENAC IN MAN, International journal of clinical pharmacology and therapeutics, 32(8), 1994, pp. 441-445
The effect of oral administration of the non-absorbable anion-exchange
resins cholestyramine and colestipol hydrochloride on the absorption
of diclofenac in man was studied. Adsorption studies in vitro were als
o performed. In a randomized crossover study consisting of three phase
s, single doses of water suspensions of colestipol hydrochloride (10 g
), or cholestyramine (8 g), or water only were given to six healthy ma
le volunteers immediately following ingestion of diclofenac (100 mg).
After dosing, serial blood samples were collected for a period of 8 ho
urs. Plasma harvested from blood was analyzed for diclofenac by a sens
itive and accurate high-performance liquid chromatographic method. The
area under the plasma concentration-time curve was moderately (33%, p
< 0.05) reduced by colestipol, and greatly reduced (62%) by cholestyr
amine. The maximum plasma concentration was reduced (58%) by colestipo
l and even more (75%) by cholestyramine treatment. The in-vitro adsorp
tion studies showed that colestipol has a weaker capacity for adsorpti
on of diclofenac compared to cholestyramine. The in-vivo data suggest
a reduction of diclofenac bioavailability when colestipol or cholestyr
amine is administered concomitantly.